Patent linkage system will hurt pharmaceutical sector

Published: 2011-12-01 06:59:00

Updated: 2011-12-01 06:59:00

The introduction of the patent linkage system following the ratification of the Korea-U.S. Free Trade Agreement is expected to deal a serious blow to the revenue of domestic drug makers.

In a local seminar on Tuesday, Dr. Chung Kwan-young of BioPharmatis Co., said that the domestic pharmaceuti...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK